We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Collaboration to Advance Data Visualization and Discovery Platform

By LabMedica International staff writers
Posted on 02 Oct 2012
Print article
PerkinElmer, Inc. (Waltham, MA, USA) and Tibco Software, Inc. (Palo Alto, CA, USA), the provider of Tibco Spotfire, a leading analytics and data discovery platform, announced that they have entered into an exclusive strategic relationship.

Under the terms of this new agreement, PerkinElmer has licensed the exclusive, worldwide rights to the Tibco Spotfire software platform in specific scientific research and development markets. These markets include basic and preclinical development applications in life sciences as well as R&D, quality assurance and quality control applications in chemical, petrochemical, environmental, food and beverage, consumer products, and academia.

This alliance will combine the depth and strength of PerkinElmer’s domain knowledge and systems with the analytic capabilities of Tibco Spotfire to provide a broader, richer set of analytic solutions for the research market. As a result, PerkinElmer will take responsibility for growing and servicing the Tibco Spotfire business in these markets.

“How scientists capture and visualize their data through the Tibco Spotfire platform is fundamental to how scientists conduct their work. Spotfire is a critical data analysis tool for the R&D community and complements PerkinElmer’s informatics offering by adding search and data visualization, which are among the most pressing business requirements of life sciences, diagnostics and environmental laboratories, worldwide,” said Mike Stapleton, general manager of informatics at PerkinElmer. “Through this strategic relationship, we are very excited to offer scientists a complete package of data generation, data management as well as data analysis and visualization to better harness information for more informed insights and decisions. The interoperability of PerkinElmer’s E-Notebook with the Tibco Spotfire platform puts all information in one place for our customers.”

One of the biggest hurdles for scientists now is the volume and diversity of data they need to gather and study to make knowledgeable and informed decisions that impact both research and business intelligence efforts. The Tibco Spotfire platform helps complete the analysis workflow by adding real time data interpretation to existing data generation and assembly tools. The data visualization tool enables researchers to instantly visualize and share data across an enterprise to reveal opportunities, avoid risks, and anticipate trends. This system can be applied to nearly every type of science and can analyze data from virtually any instrument platform.

“This new relationship is exciting news for research scientists. Our relationship with PerkinElmer will enable a broader community to benefit from the Tibco Spotfire platform and will expand the range and depth of applications serving the rapidly evolving needs of scientific research,” said Christian Marcazzo, co-head of global life sciences for Spotfire at Tibco Software Inc.

PerkinElmer is a provider of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases, and consulting services to the pharmaceutical, biotechnology, and chemical industries. The Company offers enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery and chemical research, including software, databases, and web sites that enable customers to create, analyze, and communicate chemical, biologic, and scientific data more effectively. The company reported revenue of approximately USD 1.9 billion in 2011, has approximately 7,000 employees serving customers in more than 150 countries.

Tibco Software is a provider of infrastructure software for companies to use on-premise or as part of cloud computing environments. Tibco Spotfire is the company’s in-memory analytics software for next-generation business intelligence. By offering a visual, interactive experience, Spotfire helps professionals rapidly discover new and actionable insights in information.

Related Links:

PerkinElmer
Tibco


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.